These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 16981251)
1. Characterization and over-expression of chaperonin t-complex proteins in colorectal cancer. Coghlin C; Carpenter B; Dundas SR; Lawrie LC; Telfer C; Murray GI J Pathol; 2006 Nov; 210(3):351-7. PubMed ID: 16981251 [TBL] [Abstract][Full Text] [Related]
2. Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival. Dundas SR; Lawrie LC; Rooney PH; Murray GI J Pathol; 2005 Jan; 205(1):74-81. PubMed ID: 15532096 [TBL] [Abstract][Full Text] [Related]
3. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma. Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975 [TBL] [Abstract][Full Text] [Related]
4. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype. Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496 [TBL] [Abstract][Full Text] [Related]
5. Intracellular beta-tubulin/chaperonin containing TCP1-beta complex serves as a novel chemotherapeutic target against drug-resistant tumors. Lin YF; Tsai WP; Liu HG; Liang PH Cancer Res; 2009 Sep; 69(17):6879-88. PubMed ID: 19690144 [TBL] [Abstract][Full Text] [Related]
6. Identification of the molecular mechanisms for dedifferentiation at the invasion front of colorectal cancer by a gene expression analysis. Oku Y; Shimoji T; Takifuji K; Hotta T; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Nasu T; Tamura K; Matsuura M; Miyata S; Kato Y; Yamaue H; Miki Y Clin Cancer Res; 2008 Nov; 14(22):7215-22. PubMed ID: 19010838 [TBL] [Abstract][Full Text] [Related]
7. Expression of heat shock protein 70 (HSP70) in patients with colorectal adenocarcinoma--immunohistochemistry and Western blot analysis. Milićević ZT; Petković MZ; Drndarević NC; Pavlović MD; Todorović VN Neoplasma; 2007; 54(1):37-45. PubMed ID: 17233550 [TBL] [Abstract][Full Text] [Related]
8. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of BMP7 in human colorectal cancer. Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822 [TBL] [Abstract][Full Text] [Related]
10. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis. Chen S; Liu J; Li G; Mo F; Xu X; Zhang T; Zhang X; Li J; Han X; Sun Y Scand J Gastroenterol; 2008; 43(4):456-64. PubMed ID: 18365911 [TBL] [Abstract][Full Text] [Related]
11. Analysis of single nucleotide polymorphism in the promoter and protein expression of the chemokine eotaxin-1 in colorectal cancer patients. Wågsäter D; Löfgren S; Hugander A; Dienus O; Dimberg J World J Surg Oncol; 2007 Jul; 5():84. PubMed ID: 17672898 [TBL] [Abstract][Full Text] [Related]
12. p27Kip1 is inactivated in human colorectal cancer by cytoplasmic localization associated with activation of Akt/PKB. Bottini C; Platini F; Rinaldi M; Leutner M; Alabiso O; Garavoglia M; Tessitore L Int J Oncol; 2009 Jan; 34(1):69-77. PubMed ID: 19082479 [TBL] [Abstract][Full Text] [Related]
13. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up. Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of Smac/DIABLO expression in colorectal cancer. Endo K; Kohnoe S; Watanabe A; Tashiro H; Sakata H; Morita M; Kakeji Y; Maehara Y Oncol Rep; 2009 Feb; 21(2):351-5. PubMed ID: 19148507 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of cytosolic chaperonin CCTζ-1 expression depletes proliferation of colorectal carcinoma in vitro. Qian-Lin Z; Ting-Feng W; Qi-Feng C; Min-Hua Z; Ai-Guo L J Surg Oncol; 2010 Oct; 102(5):419-23. PubMed ID: 20872946 [TBL] [Abstract][Full Text] [Related]
16. Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer. Carpenter B; McKay M; Dundas SR; Lawrie LC; Telfer C; Murray GI Br J Cancer; 2006 Oct; 95(7):921-7. PubMed ID: 16953238 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of FHIT inhibits apoptosis of colorectal cancer: mechanism and clinical implication. Cao J; Li W; Xie J; Du H; Tang W; Wang H; Chen X; Xiao W; Li Y Surg Oncol; 2006 Dec; 15(4):223-33. PubMed ID: 17382535 [TBL] [Abstract][Full Text] [Related]
18. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis. Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805 [TBL] [Abstract][Full Text] [Related]
19. Loss of p27 expression and microsatellite instability in sporadic colorectal cancer. Sarli L; Bottarelli L; Azzoni C; Campanini N; Di Cola G; Barilli AL; Marchesi F; Mazzeo A; Salvemini C; Morari S; Di Mauro D; Donadei E; Necchi F; Roncoroni L; Bordi C Surg Oncol; 2006 Aug; 15(2):97-106. PubMed ID: 17123889 [TBL] [Abstract][Full Text] [Related]
20. Expression of MAC30 protein is related to survival and biological variables in primary and metastatic colorectal cancers. Moparthi SB; Arbman G; Wallin A; Kayed H; Kleeff J; Zentgraf H; Sun XF Int J Oncol; 2007 Jan; 30(1):91-5. PubMed ID: 17143516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]